Specializing in medical devices for treating peripheral and coronary artery disease, this company develops atherectomy systems used in minimally invasive procedures. Its products are utilized by healthcare providers to remove arterial plaque, positioning it as a key player in the vascular intervention market. Investors monitor its performance due to growth potential in aging populations and increasing prevalence of cardiovascular diseases.
2 members of Congress have disclosed 2 trades in Cardiovascular Systems, Inc. (CSII), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-04-05 | Tina Smith | sell | $50K – $100K |
| 2012-05-10 | JAMES B. RENACCI | buy | $14,110.15 |